MRI-Based Delta Necrosis as a Prognostic Marker Following Neoadjuvant Chemotherapy in Soft Tissue Sarcoma.

Cancers (Basel) · 2026 · PMC12838723 · PMID 41595210

Europe PMC DOI

hedged sentence

0.1300

closest p · 2.6× alpha

0.1300

boldest claim

The sentences

a nonsignificant trendp = 0.13not close (p > 0.1)

Progression-Free Survival Patients with high pathological necrosis (≥80%) showed a nonsignificant trend toward improved PFS compared with those with poor necrosis ( p = 0.13).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.